Biomarker-based diagnosis and care pathways for Alzheimer's disease in the era of disease-modifying treatments : a consensus statement by Belgian experts

Source
European journal of neurology - ISSN 1468-1331-33:8 (2026) p.
Author(s)
    Tim Van Langenhove, Sara Van Mossevelde, Marijke Miatton, Jan De Lepeleire, Rose Bruffaerts, Jean Christophe Bier, Kurt Segers, Jurn Verschraegen, Mirko Petrovic, Manfredi Ventura, Haroun Jedidi, Ingo Beyer, Eric Mormont, Rik Vandenberghe, Aline Delva, Christian Gilles, Donatienne Van Weehaeghe, Gaëtane Picard, Peter Paul De Deyn, Mélanie Strauss, Evert Thiery, Eric Salmon, Gert Cypers, Joris Vlaemynck, Katrin Gillis, Jan Versijpt, Maria Bjerke, Anne Sieben, Bernard Hanseeuw, Sebastiaan Engelborghs, Olivier Deryck

An Adnp frameshift variant disrupts Wnt signalling inducing chromatocytoskeletal defects and autism-related behaviour in male mice

Source
EBioMedicine - ISSN 2352-3964-128 (2026) p.
Author(s)

Limited evidence for heart rate variability as a predictor of cognitive and pathophysiological brain markers

Source
Journal of Alzheimer's disease - ISSN 1387-2877-109:4 (2026) p. 1723-1732
Author(s)
    Sofia Marcolini, Jaime D. Mondragon, Arie M. van Roon, Balewgizie Sileshi Tegegne, Harriette Riese, Rozemarijn Vliegenthart, Rudi A.J.O. Dierckx, Ronald H. Borra, Peter Paul De Deyn

Integrating [¹¹C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution : a proof-of-concept study of noradrenergic vulnerability in neurodegeneration

Source
Nuclear medicine and biology - ISSN 0969-8051-152 (2026) p. 1-9
Author(s)